Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical experience with orphan drugs for rare metabolic diseases].
Caso-González A, Núñez-Rodríguez J, Nebot-Villacampa MJ, González-Pérez Y, Marín-Gorricho R, Leralta-González C, Obaldia-Alaña C. Caso-González A, et al. An Pediatr (Engl Ed). 2020 Nov 3:S1695-4033(20)30437-9. doi: 10.1016/j.anpedi.2020.09.019. Online ahead of print. An Pediatr (Engl Ed). 2020. PMID: 33158793 Free article. Spanish.
Clinical experience with orphan drugs for rare metabolic diseases.
Caso-González A, Núñez-Rodríguez J, Nebot-Villacampa MJ, González-Pérez Y, Marín-Gorricho R, Leralta-González C, Obaldia-Alaña C. Caso-González A, et al. An Pediatr (Engl Ed). 2022 Jan;96(1):8-16. doi: 10.1016/j.anpede.2020.09.014. Epub 2022 Jan 3. An Pediatr (Engl Ed). 2022. PMID: 34992005 Free article.
[Effectiveness on adherence to biological drugs and experience of a pharmaceutical intervention based on CMO model in patients with rheumatic disease (AdhER-2 study)].
Caso-González A, Núñez-Rodríguez J, González-Pérez Y, Leralta-González C, Sanz-Alonso V, Obaldia-Alaña C. Caso-González A, et al. An Sist Sanit Navar. 2022 Aug 16;45(2):e1004. doi: 10.23938/ASSN.1004. An Sist Sanit Navar. 2022. PMID: 35972301 Free PMC article. Clinical Trial. Spanish.
[Clinical experience with erenumab during the first year of treatment].
Caso-González A, Leralta-González C, Sanz-Alonso V, Iturbe-Heras M, Hernando-de la Bárcena I, Obaldia-Alaña C. Caso-González A, et al. Rev Neurol. 2022 Jan 1;74(1):8-14. doi: 10.33588/rn.7401.2021182. Rev Neurol. 2022. PMID: 34927700 Free article. Spanish.